✦ LIBER ✦
Ethical considerations and rationale of the MAKI trial: A multicenter double-blind randomized placebo-controlled trial into the preventive effect of palivizumab on recurrent wheezing associated with respiratory syncytial virus infection in children with a gestational age of 33–35 weeks
✍ Scribed by Maarten Blanken; Maroeska Rovers; Elisabeth Sanders; Louis Bont
- Book ID
- 118428111
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 304 KB
- Volume
- 33
- Category
- Article
- ISSN
- 1551-7144
No coin nor oath required. For personal study only.